Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Woo

Showing results (531-540 of 564) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|April 4, 2007
Dihydropyridopyrazinones and dihydropteridinones as corticotropin-releasing factor-1 receptor antagonists: structure-activity relationships and computational modelingCarolyn D Dzierba, Andrew J Tebben, Richard G Wilde, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Novel blood signature for hepatocellular carcinoma screeningK-M Chueng, K-N Kwok, S J-L Lam, et al.
Nature|June 6, 2020
CRISPR screen in regulatory T cells reveals modulators of Foxp3Jessica T Cortez, Elena Montauti, Eric Shifrut, et al.
Journal of Medicinal Chemistry|April 8, 2009
Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047)Han-Jie Zhou, Monette A Aujay, Mark K Bennett, et al.
Cancer Gene Therapy|February 23, 2008
Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) miceH Jin, C-X Xu, H-W Kim, et al.
Nature Cell Biology|November 18, 2022
A general approach to identify cell-permeable and synthetic anti-CRISPR small moleculesDonghyun Lim, Qingxuan Zhou, Kurt J Cox, et al.
Nature Communications|April 2, 2022
A functional map of HIV-host interactions in primary human T cellsJoseph Hiatt, Judd F Hultquist, Michael J McGregor, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|September 12, 2025
The scope and impact of original clinical research by Hong Kong public healthcare professionalsP Y M Woo, D K K Wong, Q H W Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2018
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung CancerM Catherine Pietanza, Saiama N Waqar, Lee M Krug, et al.
Cancers|September 27, 2025
Spinal Metastasis from Supratentorial Glioblastoma: A Registry-Based Case Series and a Review of the LiteratureArthur Chak Kai Lau, Desiree Ka-Ka Wong, Justin Chun Him Cheung, et al.
Pageof 57

Showing results (531-540 of 564) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|April 4, 2007
Dihydropyridopyrazinones and dihydropteridinones as corticotropin-releasing factor-1 receptor antagonists: structure-activity relationships and computational modelingCarolyn D Dzierba, Andrew J Tebben, Richard G Wilde, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Novel blood signature for hepatocellular carcinoma screeningK-M Chueng, K-N Kwok, S J-L Lam, et al.
Nature|June 6, 2020
CRISPR screen in regulatory T cells reveals modulators of Foxp3Jessica T Cortez, Elena Montauti, Eric Shifrut, et al.
Journal of Medicinal Chemistry|April 8, 2009
Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047)Han-Jie Zhou, Monette A Aujay, Mark K Bennett, et al.
Cancer Gene Therapy|February 23, 2008
Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) miceH Jin, C-X Xu, H-W Kim, et al.
Nature Cell Biology|November 18, 2022
A general approach to identify cell-permeable and synthetic anti-CRISPR small moleculesDonghyun Lim, Qingxuan Zhou, Kurt J Cox, et al.
Nature Communications|April 2, 2022
A functional map of HIV-host interactions in primary human T cellsJoseph Hiatt, Judd F Hultquist, Michael J McGregor, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|September 12, 2025
The scope and impact of original clinical research by Hong Kong public healthcare professionalsP Y M Woo, D K K Wong, Q H W Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2018
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung CancerM Catherine Pietanza, Saiama N Waqar, Lee M Krug, et al.
Cancers|September 27, 2025
Spinal Metastasis from Supratentorial Glioblastoma: A Registry-Based Case Series and a Review of the LiteratureArthur Chak Kai Lau, Desiree Ka-Ka Wong, Justin Chun Him Cheung, et al.
Pageof 57